[
  {
    "ts": "2025-12-30T04:59:42+00:00",
    "headline": "Where is Merck & Co. (MRK) Headed According to Wall Street?",
    "summary": "Merck & Co., Inc. (NYSE:MRK) is one of the best affordable healthcare stocks to buy now. Jefferies analyst Tycho Peterson reaffirmed a Buy rating on Merck & Co., Inc. (NYSE:MRK) on December 19 and set a $139.00 price target. The same day, Merck & Co., Inc. (NYSE:MRK) announced a historic agreement with the Trump administration to […]",
    "url": "https://finance.yahoo.com/news/where-merck-co-mrk-headed-045942953.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "8a4bff7d-1a37-3099-b491-955a781feb66",
      "content": {
        "id": "8a4bff7d-1a37-3099-b491-955a781feb66",
        "contentType": "STORY",
        "title": "Where is Merck & Co. (MRK) Headed According to Wall Street?",
        "description": "",
        "summary": "Merck & Co., Inc. (NYSE:MRK) is one of the best affordable healthcare stocks to buy now. Jefferies analyst Tycho Peterson reaffirmed a Buy rating on Merck & Co., Inc. (NYSE:MRK) on December 19 and set a $139.00 price target. The same day, Merck & Co., Inc. (NYSE:MRK) announced a historic agreement with the Trump administration to […]",
        "pubDate": "2025-12-30T04:59:42Z",
        "displayTime": "2025-12-30T04:59:42Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/3c1e6d485df373db04a8fd19fdaf6c3a",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Why Merck & Co (MRK) Continues to Rank Among the Most Profitable Dividend Stocks",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IzRhrl6IP..dz_8NtaA67g--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/3c1e6d485df373db04a8fd19fdaf6c3a.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/C.KM1e7Q4T5mCkqt60S1Yg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/3c1e6d485df373db04a8fd19fdaf6c3a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/where-merck-co-mrk-headed-045942953.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/where-merck-co-mrk-headed-045942953.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-30T12:59:00+00:00",
    "headline": "3 Dividend-Paying Pharma Stocks Worth Watching for Steady 2026 Gains",
    "summary": "Three dividend-paying pharma stocks stand out for steady 2026 gains as innovation, pricing deals and resilient drug demand support returns.",
    "url": "https://finance.yahoo.com/news/3-dividend-paying-pharma-stocks-125900443.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "5a92206d-fd62-3bd8-a9b7-102f498ce9f9",
      "content": {
        "id": "5a92206d-fd62-3bd8-a9b7-102f498ce9f9",
        "contentType": "STORY",
        "title": "3 Dividend-Paying Pharma Stocks Worth Watching for Steady 2026 Gains",
        "description": "",
        "summary": "Three dividend-paying pharma stocks stand out for steady 2026 gains as innovation, pricing deals and resilient drug demand support returns.",
        "pubDate": "2025-12-30T12:59:00Z",
        "displayTime": "2025-12-30T12:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-dividend-paying-pharma-stocks-125900443.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-dividend-paying-pharma-stocks-125900443.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-30T14:40:03+00:00",
    "headline": "Why Merck (MRK) is a Top Value Stock for the Long-Term",
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "url": "https://finance.yahoo.com/news/why-merck-mrk-top-value-144003079.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "345da821-4144-3ec3-9271-a9a134cb28a3",
      "content": {
        "id": "345da821-4144-3ec3-9271-a9a134cb28a3",
        "contentType": "STORY",
        "title": "Why Merck (MRK) is a Top Value Stock for the Long-Term",
        "description": "",
        "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
        "pubDate": "2025-12-30T14:40:03Z",
        "displayTime": "2025-12-30T14:40:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/98CLu2lmSTUpr4OkMLeHwg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qpn93q_5cIRTjhBkSx0KNQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-merck-mrk-top-value-144003079.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-merck-mrk-top-value-144003079.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-30T18:22:00+00:00",
    "headline": "BMY vs AMGN: Which Biotech Stock Is More Resilient Now?",
    "summary": "AMGN edges out its rival with stronger growth estimates, a broad portfolio boost from Horizon, and momentum from key drugs like Repatha and Tezspire.",
    "url": "https://finance.yahoo.com/news/bmy-vs-amgn-biotech-stock-182200740.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "226172d8-6820-35f9-87b7-8995a43f964c",
      "content": {
        "id": "226172d8-6820-35f9-87b7-8995a43f964c",
        "contentType": "STORY",
        "title": "BMY vs AMGN: Which Biotech Stock Is More Resilient Now?",
        "description": "",
        "summary": "AMGN edges out its rival with stronger growth estimates, a broad portfolio boost from Horizon, and momentum from key drugs like Repatha and Tezspire.",
        "pubDate": "2025-12-30T18:22:00Z",
        "displayTime": "2025-12-30T18:22:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/59a827b8514d5d6d47690daa5eb16f24",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xubTnAbsCPnw2obvb7FmXA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59a827b8514d5d6d47690daa5eb16f24.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lcL5Qr7_.1czomowImosdw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59a827b8514d5d6d47690daa5eb16f24.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bmy-vs-amgn-biotech-stock-182200740.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bmy-vs-amgn-biotech-stock-182200740.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-30T23:05:44+00:00",
    "headline": "FDA Fast-Tracks Two Merck (MRK) Drugs With Blockbuster Potential",
    "summary": "Merck & Co., Inc. (NYSE:MRK) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 17, the US Food and Drug Administration moved to fast-track reviews of two experimental Merck & Co., Inc. (NYSE:MRK) drugs with multibillion-dollar potential, according to internal documents seen by Reuters. Merck’s cholesterol pill enlicitide decanoate […]",
    "url": "https://finance.yahoo.com/news/fda-fast-tracks-two-merck-230544864.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "3a8bc4a1-6627-38d2-adc4-c99ee72a3038",
      "content": {
        "id": "3a8bc4a1-6627-38d2-adc4-c99ee72a3038",
        "contentType": "STORY",
        "title": "FDA Fast-Tracks Two Merck (MRK) Drugs With Blockbuster Potential",
        "description": "",
        "summary": "Merck & Co., Inc. (NYSE:MRK) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 17, the US Food and Drug Administration moved to fast-track reviews of two experimental Merck & Co., Inc. (NYSE:MRK) drugs with multibillion-dollar potential, according to internal documents seen by Reuters. Merck’s cholesterol pill enlicitide decanoate […]",
        "pubDate": "2025-12-30T23:05:44Z",
        "displayTime": "2025-12-30T23:05:44Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/94df0d7efd0c849009047c4ea497a8ca",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "FDA Fast-Tracks Two Merck (MRK) Drugs With Blockbuster Potential",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FDKnY5uNA.3OTPtx1WZHpg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/94df0d7efd0c849009047c4ea497a8ca.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4E_Xp0qL7v88XazDkShaxw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/94df0d7efd0c849009047c4ea497a8ca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fda-fast-tracks-two-merck-230544864.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-fast-tracks-two-merck-230544864.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]